Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma
Clinical trial NCT07014150 · RECRUITING
Trial details
- NCT number
- NCT07014150
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-10
- Primary completion
- 2027-05-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.